Cytosorbents Corp (CTSO): Shareholders' Equity
$5.90M
As of 2025-12-31
-$751.0K
As of 2026-06-30
-44.9%
3-year compound annual growth
-40.5%
5-year compound annual growth
-5.0%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.90M | -46.9% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $11.11M | n/a | 2026-03-30, Balance as of period end |
| 2024-09-30 | $13.14M | n/a | 2025-03-31, Balance as of period end |
| 2024-06-30 | $17.43M | n/a | 2025-03-31, Balance as of period end |
| 2024-03-31 | $19.63M | n/a | 2025-03-31, Balance as of period end |
| 2023-12-31 | $23.48M | n/a | 2025-03-31, Balance as of period end |
| 2023-09-30 | $18.81M | n/a | 2025-03-31, Balance as of period end |
| 2023-06-30 | $24.46M | n/a | 2025-03-31, Balance as of period end |
| 2023-03-31 | $29.94M | n/a | 2025-03-31, Balance as of period end |
| 2022-12-31 | $35.37M | -43.5% | 2024-03-15, Balance as of period end |
| 2021-12-31 | $62.58M | -21.0% | 2024-03-15, Balance as of period end |
| 2020-12-31 | $79.22M | n/m | 2023-03-09, Balance as of period end |
| 2019-12-31 | $3.42M | -79.8% | 2022-03-10, Balance as of period end |
| 2018-12-31 | $16.93M | +65.0% | 2021-03-09, Balance as of period end |
| 2017-12-31 | $10.26M | +667.3% | 2020-03-05, Balance as of period end |
| 2016-12-31 | $1.34M | -86.4% | 2019-03-07, Balance as of period end |
| 2015-12-31 | $9.85M | n/c | 2018-03-08, Balance as of period end |
| 2014-12-31 | $3.96M | n/m | 2017-03-03, Balance as of period end |
| 2013-12-31 | -$14.27M | n/m | 2015-03-31, Balance as of period end |
| 2012-12-31 | -$11.63M | n/m | 2014-03-31, Balance as of period end |
| 2011-12-31 | -$10.09M | n/m | 2014-03-31, Balance as of period end |
| 2010-12-31 | -$8.07M | n/m | 2014-03-31, Balance as of period end |
| 2009-12-31 | -$5.74M | n/m | 2014-03-31, Balance as of period end |
| 2008-12-31 | -$3.35M | n/m | 2014-03-31, Balance as of period end |
| 2007-12-31 | -$104.3K | n/m | 2014-03-31, Balance as of period end |
| 2006-12-31 | $2.36M | n/m | 2014-03-31, Balance as of period end |
| 2005-12-31 | -$9.76M | n/m | 2014-03-31, Balance as of period end |
| 2004-12-31 | -$6.97M | n/m | 2014-03-31, Balance as of period end |
| 2003-12-31 | -$3.91M | n/m | 2014-03-31, Balance as of period end |
| 2002-12-31 | -$4.37M | n/m | 2014-03-31, Balance as of period end |
| 2001-12-31 | $2.33M | -56.4% | 2014-03-31, Balance as of period end |
| 2000-12-31 | $5.34M | n/m | 2014-03-31, Balance as of period end |
| 1999-12-31 | $100.5K | -93.6% | 2014-03-31, Balance as of period end |
| 1998-12-31 | $1.58M | +80.1% | 2014-03-31, Balance as of period end |
| 1997-12-31 | $877.5K | n/a | 2014-03-31, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Cytosorbents Corp (CTSO) | 2025-12-31 | $5.90M | -46.9% |
| ClearPoint Neuro, Inc. (CLPT) | 2025-12-31 | $28.02M | +10.4% |
| Retractable Technologies Inc (RVP) | 2025-12-31 | $74.38M | -14.7% |
| Utah Medical Products Inc (UTMD) | 2025-12-31 | $119.27M | +1.6% |
| Interpace Biosciences, Inc. (IDXG) | 2025-12-31 | $22.36M | n/m |
| Orchestra BioMed Holdings, Inc. (OBIO) | 2025-12-31 | $53.57M | +62.5% |
| KORU Medical Systems, Inc. (KRMD) | 2025-12-31 | $17.05M | +1.4% |
| SS Innovations International, Inc. (SSII) | 2025-12-31 | $38.22M | +184.0% |
| Premier Air Charter Holdings Inc. (PREM) | 2025-12-31 | $3.97M | n/m |
Compare CTSO, CLPT, RVP, UTMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗